Navarro, Angel M.
HRN: 21-65-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2022
MUPIROCIN 2%, 15G (TUBE)
07/26/2022
07/31/2022
TOPICAL
2%
Tid
Abrasio
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes